Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats

Archives of Pharmacal Research

Volumn 31, Issue 12, 2008, Pages 1564-1571

  Yoon, Na Young ^a   Kim, Hyeung Rak ^a   Chung, Hae Young ^b   Choi, Jae Sue ^a  

^a Pukyong National University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Ecklonia stolonifera; High cholesterol diet; Hyperlipidemic; Phlorotannin; Poloxamer 407; Rats

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; BUTANOL; DIECKOL; ECKLONIA STOLONIFERA EXTRACT; ECKOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NATURAL PRODUCT; PHLOROTANNIN; POLOXAMER; TANNIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BROWN ALGA; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; ECKLONIA STOLONIFERA; HYPERLIPIDEMIA; MALE; MARINE SPECIES; NONHUMAN; RAT;

ALGAE, BROWN; ANIMALS; ANTILIPEMIC AGENTS; BENZOFURANS; CHOLESTEROL, DIETARY; DIET; DIOXINS; ETHANOL; FREEZE DRYING; HYPERLIPIDEMIAS; MALE; POLOXAMER; RATS; RATS, SPRAGUE-DAWLEY; SOLVENTS; TANNINS; TRIGLYCERIDES;

EID: 58449103316     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-2152-8     Document Type: Article

References (50)

1. M. J. Ahn K. D. Yoon C. Y. Kim S. Y. Min Y. U. Kim H. J. Kim J. H. Kim C. G. Shin C. K. Lee T. G. Kim S. H. Kim H. Huh J. W. Kim 2002 Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts J. Appl. Phycol. 14 325 329
2. J. Ara V. Sultana R. Qasim V. U. Ahmad 2002 Hypolipidemic activity of seaweed from Karachi Coast Phytother. Res. 16 479 483
3. J. A. Berliner J. W. Heinecks 1996 The role of oxidized lipoproteins in atherogenesis Free Radical Biol. Med. 20 707
4. J. S. Choi T. Yokozawa H. Oura 1991 Antihyperlipidemic effect of flavonoids from Prunus davidiana J. Nat. Prod. 54 218 224
5. V. C. Cogger A. Warren R. Fraser M. Nqu A. J. McLean D. G. Le Couteur 2003 Hepatic sinusoidal pseudocapillarization with aging in the non-human primate Exp. Gerontol. 38 1101 1107
6. G. M. Dallinga-Thie I.I. Berk-Planken A. H. Bootsma H. Jansen 2004 Diabetes atorvastatin lipid intervention (DALI) Study Group, Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides Diabetes Care 27 1358 1364
7. De Bono, D. P. and Boon, N. A., Diseases of the cardiovascular system. In: Edwards, C. R. W., and Bouchier, I. A. D. (Eds.). Davidson's principles and practice of medicine. ELBS Churchill Livingstone, Edinburgh, pp. 249-340 (1992).
8. J. C. Elwood D. T. Nash D. H. Streeten 1982 Effect of highchromium brewer's yeast on human serum lipids J. Am. Coll. Nutr. 1 263 274
9. G. Feussner 1994 HMG-CoA reductase inhibitors Curr. Opin. Lipidiol. 5 59 60
10. I. Fki M. Bouaziz Z. Sahnoun S. Sayadi 2005 Hypocholesterolemic effects of phenolic-rich extracts of Chemlali olive cultivar in rats fed a cholesterol-rich diet Bioorg. Med. Chem. 13 5362 5370
11. S. M. Grundy 1993 Summary of the second report of the National Cholesterol Education Program (NCEP) export panel on detection, evaluation and treatment of high blood cholesterol in adults JAMA. 269 3015 3023
12. W. L. Isley J. M. Miles B. W. Parrerson W. S. Harris 2006 The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus J. Lipid Res. 47 193 200
13. K. S. John M. K. Kathiravan R. S. Somani C. J. Shishoo 2005 The biology and chemistry of hyperlipidemia Bioorg. Med. Chem. 15 4674 4699
14. T. P. Johnston W. K. Palmer 1997 Effect of poloxamer 407 on the activity of microsomal 3-hydroxy-3-methylglutaryl CoA reductase in rats J. Cardiovasc. Pharmacol. 29 580 585
15. H. A. Jung S. K. Hyun H. R. Kim J. S. Choi 2006 Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera Fisheries Sci. 72 1292 1299
16. H. S. Kang H. Y. Chung J. H. Jung B. W. Son J. S. Choi 2003 A new phlorotannin from the brown alga Ecklonia stolonifera Chem. Pharm. Bull. 51 1012 1014
17. H. S. Kang H. Y. Chung J. Y. Kim B. W. Son H. A. Jung J. S. Choi 2004 Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation Arch. Pharm. Res. 27 194 198
18. J. M. Kim N. S. Seong Y. J. Lee 2001 The effects of jwa kum-wham and soo ryeon-whan on the hyperlipidemia in rats Korean J. Herbology 20 91 102
19. Y. C. Kim R. B. An N. Y. Yoon T. J. Nam J. S. Choi 2005 Hepatoprotective constituents of the edible brown alga Ecklonia stolonifera on tacrine-induced cytotoxicity in Hep G2 cell Arch. Pharm. Res. 28 1376 1380
20. Y. M. Kim C. K. Han S. J. Bang J. H. Park 2006 Effect of laminaran from Eisenia bicyclis on serum lipid in rats fed high cholesterol diet J. Kor. Soc. Food Sci. Nutr. 35 841 846
21. Y. Kimura K. Watanabe H. Okuda 1996 Effects of soluble sodium alginate on cholesterol excretion and glucose tolerance in rats J. Ethnopharmacol. 54 47 54
22. P. Libby M. Aikawa U. Schinbeck 2000 Cholesterol and atherosclerosis Biochim. Biophys. Acta. 1529 299 309
23. J. M. McKenney 2001 Pharmacotherapy of dyslipidemia Cardiovasc. Drugs Ther. 15 413 422
24. S. Megalli F. Aktan N. M. Davies B. D. Roufogalis 2005 Phytopreventative anti-hyperlipidemic effects of Gynostemma pentaphyllum in rats J. Pharm. Pharm. Sci. 8 507 515
25. Michanek, G., Seaweed resources for pharmaceutical uses. In: Hoppe, H. A., Levring, T., and Tanaka, Y. (Eds.). Marine Algae in Pharmaceutical Science. Walter de Gruyter, Berlin, New York, pp. 303-342 (1979).
26. D. W. Moral J. R. Hessler G. M. Chisolm 1983 Low density lipoprotein cytotoxicity induced by free radical peroxydation of lipid J. Lipid Research 24 1070 1076
27. M. Navab J. A. Berliner A. D. Watson S. Y. Hama M. C. Territo A. J. Lusis D. M. Shih B. J. Van Lenten J. S. Frank L. L. Demer P. A. Edwards A. M. Fogelman 1996 The yin and yang of oxidation in the development of the fatty streak: a review based on the 1994 george lyman duff memorial lecture Arterioscler. Thromb. Vasc. Biol. 16 839 842
28. F. Nigon C. Serfaty-Lacrosniere I. Beucler I. Beucler D. Chauvois C. Neveu P. Giral M. J. Chapman E. Bruckert 2001 Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment Clin. Chem. Lab. Med. 39 634 640
29. J. M. O'Keefe Jr. C. J. Lavie Jr. B. D. McCallister 1995 Insight into the pathogenesis and prevention of coronary artery disease May. Clinic Proceeding 70 69 79
30. L. B. Oliveros A. M. Videla D. C. Ramirez M. S. Gimenez 2003 Dietary fat saturation produces lipid modifications in peritoneal macrophage of mouse J. Nutr. Biochem. 14 370 377
31. C. S. Park E. K. Hwang S. J. Lee K. W. Roh C. H. Sohn 1994 Age of growth of Ecklonia stolonifera Okamura in Pusan bay, Korea Bull. Korean Fish. Soc. 27 390 396
32. Y. Pengzhan L. Ning L. Xiguang Z. Gefei Z. Quanbin L. Pengcheng 2003 Antihyperlipidemic effects of different molecular weight sulfated polysaccharides from Ulva pertusa (Chlorophyta) Pharmacol. Res. 48 543 549
33. J. Raymond A. Metcalfe I. Salazkin A. Schwarz 2004 Temporary vascular occlusion with poloxamer 407 Biomaterials 25 3983 3989
34. E. J. Ricci L. D. Lunardi D. M. Nauclares J. M. Marchetti 2005 Sustained release of lidocaine from poloxamer 407 gels Int. J. Pharm. 288 235 244
35. H. S. Ro O. J. Kim K. K. Park T. H. Cho H. S. Park 1994 Studies on diet regimens for the development of hyperlipidemic animal model J. Kor. Pharm. Sci. 24 297 321
36. R. Ross 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 801 809
37. S. Rota N. A. McWilliam T. P. Baglin C. D. Byrne 1998 Atherogenic lipoproteins support assembly of the prothrombinase complex and thrombin generation modulation by oxidation and vitamin E Blood 91 509 515
38. V. Sanna N. Kirschvink P. Gustin E. Garini I. Roland L. Delattre B. Evrard 2004 Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration AAPS. Pharm. Sci. Tech. 5 e27
39. E. J. Schaefer A. H. Lichtenstein S. Lamom-Fava J. R. McNamara J. M. Ordovas 1995 Lipoproteins, nutrition, aging, and atherosclerosis Am. J. Clin. Nutr. 61 726S 740S
40. Schmolka, I. R., Poloxamers in the pharmaceutical industry. In: Tarch, P. J. (Ed.). Polymers for controlled drug delivery. CSC Press, Boca Raton, pp. 189-215 (1991).
41. D. R. Sliskovic A. D. White 1991 Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents Trends Pharmacol. Sci. 12 194 199
42. Z. Szilvassy T. Csont T. Pali M. T. Droy-lefaix P. Ferdinandy 2001 Nitric oxide, peroxinitrite and cGMP in atheroscleosis-induced hypertention in rabbits: beneficial effects of cicleranine J. Vasc. Res. 38 39 46
43. Talbert, R., Hyperlipidemia, DePiro Textbook of Threrapeytics. Appleton and Lange, Connecticut, pp. 357-386 (1997).
44. K. Taniguchi K. Kurata M. Suzuki 1991 Feeding-deterrent effect of phlorotannins from the brown alga Ecklonia stolonifera against the abalone Haliotis discushannai Nippon Suisan Gakkaishi 57 2065 2071
45. N. J. Wald M. R. Law 1995 Serum cholesterol and ischemic heart disease Atherosclerosis 118 S1 S5
46. C. R. White T. A. Brock L. Y. Chang J. Crapo P. Briscoe D. Ku W. A. Bardley S. H. Gianturco J. Gore B. A. Freeman M. M. Tarpey 1994 Superoxide and peroxinitrite in atherosclerosis Proc. Natl. Acad. Sci. USA 91 1044 1048
47. Z. G. Wout E. A. Pec J. A. Maggiore 1992 Poloxamer 407-mediated changes in plasma cholesterol and triglycerides following intraperitoneal injection to rats J. Parenter. Sci. Technol. 46 192 200
48. K. Yamada Y. Tokunaga A. Ikeda K. Ohkura S. Kaku-Ohkura S. Mamiya B. O. Lim H. Tachibana 2003 Effect of dietary fiber on the lipid metabolism and immune function of aged Sprague-Dawley rats Biosci. Biotechnol. Biochem. 67 429 433
49. S. Yasuda D. Townsend D. E. Michele E. G. Favre S. M. Day J. M. Metzger 2005 Dystrophic heart failure blocked by membrane sealant poloxamer Nature 436 1025 1029
50. T. Yokozawa E. J. Cho S. Sasaki A. Satoh T. Okamato Y. Sei 2006 The protective role of Chinese prescription kangen-karyu extract on diet-induced hypercholesterolemia in rats Biol. Pharm. Bull. 29 760 765